Table 3.
Factors associated with good adherence
| Parameter | β | OR (95%CI) |
| Age (yr) | ||
| 18-45 vs ≤ 18a | -0.3297 | 0.719 (0.559-0.926) |
| > 45 vs ≤ 18b | -0.4048 | 0.667 (0.513-0.867) |
| Gender (1 = male; 0 = female) | -0.0382 | 0.963 (0.886-1.046) |
| Insurance type (1 = medical insurance; 0 = paid out-of-pocket) | 0.1200 | 1.128 (0.987-1.288) |
| Disease status (1 =; 0 = reference;)b | 0.2516 | 1.286 (1.164-1.422) |
| Patient status (1 = new patients; 0 = existing patients) | -0.0341 | 0.966 (0.860-1.086) |
| Reimbursement implementation (1 = Yes; 0 = No)b | 0.1502 | 1.162 (1.047-1.290) |
| Insurance type patient statusa | -0.1980 | 0.820 (0.703-0.957) |
| Insurance type reimbursement implementationb | 0.3518 | 1.422 (1.220-1.657) |
a
P < 0.05;
b
P < 0.01, new vs existing patients. 1 = having one of the following characteristics: (1) serum alanine aminotransferase over two times upper limit of normal; (2) alanine aminotransferase DNA ≥ 20000 IU/mL for hepatitis B e antigen (HBeAg) (+) patients; or (3) HBV DNA ≥ 2000 IU/mL for HBeAg (-) patients.